Literature DB >> 22745483

The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).

Jessie A Turnbaugh1, Ursula Unterberger, Paula Saá, Tania Massignan, Brian R Fluharty, Frederick P Bowman, Michael B Miller, Surachai Supattapone, Emiliano Biasini, David A Harris.   

Abstract

Prion propagation involves a templating reaction in which the infectious form of the prion protein (PrP(Sc)) binds to the cellular form (PrP(C)), generating additional molecules of PrP(Sc). While several regions of the PrP(C) molecule have been suggested to play a role in PrP(Sc) formation based on in vitro studies, the contribution of these regions in vivo is unclear. Here, we report that mice expressing PrP deleted for a short, polybasic region at the N terminus (residues 23-31) display a dramatically reduced susceptibility to prion infection and accumulate greatly reduced levels of PrP(Sc). These results, in combination with biochemical data, demonstrate that residues 23-31 represent a critical site on PrP(C) that binds to PrP(Sc) and is essential for efficient prion propagation. It may be possible to specifically target this region for treatment of prion diseases as well as other neurodegenerative disorders due to β-sheet-rich oligomers that bind to PrP(C).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22745483      PMCID: PMC3433751          DOI: 10.1523/JNEUROSCI.1103-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  A nine amino acid domain is essential for mutant prion protein toxicity.

Authors:  Laura Westergard; Jessie A Turnbaugh; David A Harris
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

2.  Identification of the heparan sulfate binding sites in the cellular prion protein.

Authors:  Richard G Warner; Christoph Hundt; Stefan Weiss; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2002-03-06       Impact factor: 5.157

3.  Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein.

Authors:  Max Nunziante; Sabine Gilch; Hermann M Schätzl
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

4.  Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease.

Authors:  G J Raymond; A Bossers; L D Raymond; K I O'Rourke; L E McHolland; P K Bryant; M W Miller; E S Williams; M Smits; B Caughey
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

Review 5.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

6.  Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites.

Authors:  Darragh B Freir; Andrew J Nicoll; Igor Klyubin; Silvia Panico; Jessica M Mc Donald; Emmanuel Risse; Emmanuel A Asante; Mark A Farrow; Richard B Sessions; Helen R Saibil; Anthony R Clarke; Michael J Rowan; Dominic M Walsh; John Collinge
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

7.  Cell-surface prion protein interacts with glycosaminoglycans.

Authors:  Tao Pan; Boon-Seng Wong; Tong Liu; Ruliang Li; Robert B Petersen; Man-Sun Sy
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

Review 8.  Prion diseases: what is the neurotoxic molecule?

Authors:  R Chiesa; D A Harris
Journal:  Neurobiol Dis       Date:  2001-10       Impact factor: 5.996

9.  The N-terminal, polybasic region is critical for prion protein neuroprotective activity.

Authors:  Jessie A Turnbaugh; Laura Westergard; Ursula Unterberger; Emiliano Biasini; David A Harris
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

10.  Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.

Authors:  Michael B Miller; James C Geoghegan; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

View more
  38 in total

1.  MEK1 transduces the prion protein N2 fragment antioxidant effects.

Authors:  C L Haigh; A R McGlade; S J Collins
Journal:  Cell Mol Life Sci       Date:  2014-11-13       Impact factor: 9.261

2.  Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.

Authors:  Raphaël Rouget; Gyanesh Sharma; Andréa C LeBlanc
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

3.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

4.  PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicity.

Authors:  David Mengel; Wei Hong; Grant T Corbett; Wen Liu; Alexandra DeSousa; Laura Solforosi; Cheng Fang; Matthew P Frosch; John Collinge; David A Harris; Dominic M Walsh
Journal:  Brain Res       Date:  2018-12-26       Impact factor: 3.252

5.  A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location.

Authors:  N C Ferreira; L M Ascari; A G Hughson; G R Cavalheiro; C F Góes; P N Fernandes; J R Hollister; R A da Conceição; D S Silva; A M T Souza; M L C Barbosa; F A Lara; R A P Martins; B Caughey; Y Cordeiro
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

6.  A C-terminal membrane anchor affects the interactions of prion proteins with lipid membranes.

Authors:  Nam K Chu; Waheed Shabbir; Erin Bove-Fenderson; Can Araman; Rosa Lemmens-Gruber; David A Harris; Christian F W Becker
Journal:  J Biol Chem       Date:  2014-09-12       Impact factor: 5.157

Review 7.  Prion neurotoxicity.

Authors:  Nhat T T Le; Bei Wu; David A Harris
Journal:  Brain Pathol       Date:  2019-01-17       Impact factor: 6.508

8.  Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.

Authors:  Taichi Hamanaka; Keiko Nishizawa; Yuji Sakasegawa; Ayumi Oguma; Kenta Teruya; Hiroshi Kurahashi; Hideyuki Hara; Suehiro Sakaguchi; Katsumi Doh-Ura
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

Review 9.  Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.

Authors:  Maxime Béland; Xavier Roucou
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

10.  Homodimerization as a molecular switch between low and high efficiency PrP C cell surface delivery and neuroprotective activity.

Authors:  Maxime Béland; Xavier Roucou
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.